In this study, we describe the presence of CTX-M-1 b-lactamase in two clinical bacterial strains of P. aeruginosa and S. maltophilia.
P. aeruginosa and S. maltophilia strains were isolated during a prevalence study on ESBLs in May 2004 in Amsterdam at the microbiological laboratory of the Academic Medical Center (AMC). The P. aeruginosa strain was isolated from the sputum of a 21-year-old male cystic fibrosis outpatient. The S. maltophilia strain was isolated from the sputum of a hospitalized, male neonate at the Department of Neonatology at AMC. Neither patient showed any signs of invasive infection due to the presence of these strains. Antimicrobial regimens before admission were not documented and the patients were not receiving any antibiotic treatment at the time of isolation of these strains.
The strains were identified as P. aeruginosa and S. maltophilia using VITEK-2 (bioMérieux) and classical biochemical determination (routine determination at the microbiology laboratory). Species determination was confirmed by PCR and sequence analysis of the 16S rRNA gene, using the generic primers p515F (59-TGCCAGCAGCCGCGGTAA-39) and p13b (59-AGGCCCGGGAACGTATTCAC-39) (Relman et al., 1992) .
Antibiotic susceptibilities were determined according to the guidelines of the National Committee for Clinical Laboratory Standards (NCCLS) with the disc diffusion method (NCCLS, 2005) . ESBL production was detected using a combination of the double disc test and the combined disc test (DCDT) (N. al Naiemi, B. Duim, V. van der Veen, M. D. de Jong & A. Bart, unpublished data), which included discs of ceftazidime, cefotaxime, cefpodoxime and cefepime placed around a disc containing amoxycillin plus clavulanate. The test was done at two distances between the discs: 30 and 20 mm (centre to centre). The DCDT also included a disc containing ceftazidime plus clavulanate and a disc containing cefoxitin for detection of AmpC production.
The presence of the ESBL genes bla SHV , bla TEM and bla CTX-M was determined by PCR and sequence analysis using bla SHV -and bla TEM -specific primers as described previously (al Naiemi et al., 2005) and primers CTX-MA-F1 (59-CGYTTTSCRATGTGCAG-39) and CTX-MB-F2 (59-ACCGCRATATCRTT-GGT-39), slightly modified from primers used by Bonnet et al. (2001) . To prevent carry-over contamination, the Uracil system (Roche) was applied and ultrahigh-purity water was used as a negative control. The PCR conditions were identical to those described previously (al Naiemi et al., 2005) . Both DNA strands were sequenced with the amplification primers and two additional internal bla SHV and bla TEM primers as described previously (al Naiemi et al., 2005) .
The ESBL phenotype of the P. aeruginosa and S. maltophilia strains is shown in Fig. 1 . As the P. aeruginosa isolate was sensitive to inhibition by clavulanate (Fig. 1) , the action of OXA b-lactamases, which are frequently present in P. aeruginosa, is unlikely (Bradford, 2001) . The susceptibility of this P. aeruginosa strain for cefoxitin is noteworthy. P. aeruginosa is usually resistant to cefoxitin, as it contains an inducible AmpC enzyme (Livermore, 1991) . However, failure of cefoxitin to induce AmpC production in P. aeruginosa has been reported previously (Ramadan et al., 1995) .
PCR and sequence analysis revealed the presence of the bla CTX-M-1 , bla SHV-1 and bla TEM-116 genes in the P. aeruginosa strain and bla CTX-M-1 and bla SHV-1 in the S. maltophilia strain. Of these b-lactamases, only CTX-M-1 has been shown to produce a transferable ESBL phenotype (Sirot et al., 1987) .
To our knowledge, this is the first description of the presence of CTX-M ESBLs in P. aeruginosa and S. maltophilia. The CTX-M ESBLs provide these pathogens with an additional powerful resistance mechanism with potential serious clinical implications, including limitation of the therapeutic options.
It remains to be determined how the CTX-M-1 genes have disseminated to these JMM Correspondence P. aeruginosa and S. maltophilia strains. The association of CTX-M b-lactamaseencoding genes with mobile elements such as the ISEcp1 insertion element and integrons (Eckert et al., 2006) may facilitate the spread of bla CTX-M genes among bacteria.
As phenotypic detection of ESBLs in nonfermenters is complicated and many clinical microbiological laboratories have no routine surveillance of ESBLs in nonfermenters, ESBLs may be underestimated and underreported in these strains. Therefore, P. aeruginosa and S. maltophilia may become hidden reservoirs for such ESBLs, as is already the case for OXA b-lactamases in P. aeruginosa. DCDT for S. maltophilia with CTX-M-1, at 30 mm distance between the discs (centre to centre). Production of ESBL is indicated by the synergy between the CAZ, CTX and CFP discs and the AM/CL disc (arrows). In addition, the CAZ/CL zone was ¢5 mm larger than that of CAZ, indicating the production of ESBL. (b) DCDT for P. aeruginosa with CTX-M-1, at 20 mm distance between the discs (centre to centre). Synergy is evident between the CFP and CAZ discs and the AM/CL disc, indicating the production of ESBL. The CAZ/CL zone was ¢5 mm larger than that of CAZ, indicating the production of ESBL. CFP, Cefepime; CPD, cefpodoxime; AM/CL, amoxycillin/clavulanate; CTX, cefotaxime; CAZ, ceftazidime; FOX, cefoxitin; CAZ/CL, ceftazidime/clavulanate.
